Publication - Abstract
Sep 17, 2019
Expert Opinion on Drug Delivery
October 24, 2019
Publication - Abstract
Sep 17, 2019
Expert Opinion on Drug Delivery
Publication - Abstract
Aug 18, 2020
Nucleic Acids Research
In this paper Alnylam Pharmaceuticals, developer of RNAi therapeutics ONPATTRO® and GIVLAARI®, investigates the biological origins of the extended duration of N-acetylgalactosamine silencing RNA (GalNAc-siRNA) activity observed in vivo.